Fu S, Zhou Y, Xu H. Primary fibroblastic osteosarcoma of sternum: A case report.
Medicine (Baltimore) 2022;
101:e28827. [PMID:
35363174 PMCID:
PMC9282063 DOI:
10.1097/md.0000000000028827]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Accepted: 01/28/2022] [Indexed: 01/04/2023] Open
Abstract
RATIONALE
Osteosarcoma, a malignant bone tumor, rarely occurs in the sternum, especially the fibroblastic type, and is associated with poor survival. This case report describes a patient with a neoplasm of the sternum who underwent tumor resection 3 times and reconstruction twice because of the high risk of recurrence.
PATIENT CONCERNS
A 60-year-old Chinese man presented with a 3-cm palpable bulging mass located in front of his sternum. Chest computed tomography (CT) revealed an anterior chest wall neoplasm with sternal destruction.
DIAGNOSIS
Pathological examination revealed that the mass was a low-grade malignant primary fibroblastic osteosarcoma.
INTERVENTIONS
Locking plates were used for chest wall reconstruction, demonstrating good structural stability and economic applicability. Regarding the ineffectiveness of current therapies, whole-exome sequencing was conducted, and no targets matched any of the currently available agents.
OUTCOMES
No recurrence was found on regular reexamination.
LESSONS
Surgery is the first choice of treatment for patients with primary fibroblastic osteosarcoma of the sternum. The reconstruction-locking plate is a good alternative for chest wall reconstruction. Whole-exome sequencing can shed new light on this uncommon disease and help identify novel therapeutic targets.
Collapse